Janus Henderson Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,203	Closed	-$1.09M	–	2727
2023 Q1	$1.09M	Buy	10,203 +5,617	+122%	+$603K	﹤0.01%	1581
2022 Q4	$504K	Buy	+4,586	New	+$504K	﹤0.01%	1714